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Abstract
Background: Nonsense-mediated mRNA decay (NMD) is a post-transcriptional RNA surveillance process that facilitates the
recognition and destruction of mRNAs bearing premature terminations codons (PTCs). Such PTC-containing (PTC+) mRNAs
may arise from different processes, including erroneous processing and expression of pseudogenes, but also from more
regulated events such as alternative splicing coupled NMD (AS-NMD). Thus, the NMD pathway serves both as a silencer of
genomic noise and a regulator of gene expression. Given the early embryonic lethality in NMD deficient mice, uncovering
the full regulatory potential of the NMD pathway in mammals will require the functional assessment of NMD in different
tissues.
Methodology/Principal Findings: Here we use mouse genetics to address the role of UPF2, a core NMD component, in the
development, function and regeneration of the liver. We find that loss of NMD during fetal liver development is
incompatible with postnatal life due to failure of terminal differentiation. Moreover, deletion of Upf2 in the adult liver results
in hepatosteatosis and disruption of liver homeostasis. Finally, NMD was found to be absolutely required for liver
regeneration.
Conclusion/Significance: Collectively, our data demonstrate the critical role of the NMD pathway in liver development,
function and regeneration and highlights the importance of NMD for mammalian biology.
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Introduction
The NMD machinery is part of a larger set of RNA surveillance
pathways that check the integrity of mRNAs before rendering
them available for translation in the cytoplasm. Specifically, NMD
recognizes mRNAs containing PTCs and routes them towards
degradation, thereby providing molecular means to avoid the
production of C-terminally truncated protein from damaged
mRNAs [1,2].
The molecular rules by which stop codons are recognized as
premature have been elucidated in organisms ranging from yeast
to man. In mammals, the exon junction complex (EJC), which is a
protein complex deposited upstream of the exon-exon junction
during splicing, has long been considered as the marker
distinguishing premature from normal stop codons [2,3]. As most
mammalian genes carry their termination codon in the last exon, a
stop codon located upstream of an EJC marks it as premature.
Whereas this model explains many features of mammalian NMD,
it fails to explain why some stop codons without a downstream
EJC are recognized as PTCs. Recently, it has been demonstrated
that also the distance of the stop codon to the poly(A) tail can
determine whether a stop codon is recognized as normal or
premature [4,5,6].
PTC-containing (PTC+) ‘‘erroneous’’ mRNAs may arise from
transcription of pseudogenes, from nucleotide misincorporation
during transcription of bona fide genes, or more frequently due to
processing errors during the posttranscriptional maturation of the
primary transcript [7,8]. In addition to serve as a ‘‘filter’’ of genetic
noise, the NMD machinery has also been described as an
important regulator of mRNA output. Most prominent is its role
in a process termed AS-NMD, in which an alternative splicing
event results in the generation of two mRNA isoforms, one of them
being NMD sensitive [9,10,11]. Intriguingly, AS-NMD is
particular frequent among splicing factors and the ability of some
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own mRNAs sets up a series of autoregulatory loops by which
homeostasis of these factors are maintained [9,10]. Obviously,
disruption of these loops, for instance by ablation of NMD, may
have profound effects on alternative splicing in general. Finally,
the NMD pathway has also been reported to modulate the
expression of several normal genes by mechanisms involving the
presence of an upstream open reading frame or an intron in the 39
untranslated region, both of which are predicted to elicit NMD
[12,13]. To what extent this is used in a regulatory context is not
clear, but it has been proposed that different tissues display
different efficiencies of NMD, which in turn may lead to tissue-
specific differences in mRNAs containing NMD features [14].
The molecular components of the NMD machinery in
mammals have been reported to consist of at least 9 members:
UPF1, UPF2 and UPF3a/b constitutes the core NMD complex
and is conserved from yeast to man [2]. SMG1, SMG5 and SMG7
are later evolutionary additions to the NMD machinery and are
involved in a phosphorylation/dephosphorylation cycle of UPF1
necessary for NMD [15]. SMG6 has recently been described as an
endonuclease involved in cleavage of NMD substrates, whereas
the functions of the newest members of NMD machinery SMG8
and SMG9 are only partially defined [16,17]. Besides their
established importance in the NMD process per se, NMD
components have also been reported to play roles in other cellular
pathways. These include the DNA damage response (SMG1,
UPF1 [15,18]), cell cycle progression (SMG1, UPF1, SMG6
[18,19]) and in telomere maintenance (SMG1, UPF1, SMG6
[20]).
Whereas the NMD pathway has been extensively studied in
tissue-culture we have very limited insights into its roles in the
context of intact mammalian organisms. Mice lacking either UPF1
or UPF2 die early during embryonic development and have
therefore not been amenable to detailed analysis [13,21].
Recently, we reported on the characterization of mouse lines
lacking UPF2 in various hematopoietic compartments [13]. Here
we uncovered an essential role for UPF2 in proliferating cells and
in degrading PTC+ transcripts from genomic rearrangement by-
products during lymphoid development. Furthermore, we showed
that the NMD machinery regulates the expression of specific
subsets of genes including snoRNA host genes and is instrumental
in AS-NMD in vivo. Despite these findings we completely lack
knowledge on the role of NMD in other tissues.
The mammalian liver is a complex organ, which plays several
different roles during embryonic development and in adult life.
During fetal life the developing liver serves as the main
hematopoietic organ, whereas its primary function in the adult is
metabolic processes, including detoxification, glycogen storage as
well as hormone and plasma protein production.
Liver development in the mouse initiates at embryonic day (E)
8.5 from an area of the primitive gut endoderm that is specified by
signals from the cardiac mesoderm and the surrounding
mesenchyme [22]. These signals ultimately result in the prolifer-
ation of hepatoblasts followed by their migration into the
surrounding mesenchyme. At the later stages of liver development,
hepatoblasts terminally differentiate into hepatocytes and cholan-
giocytes, the two hepatic cell lineages, in a process involving
epithelial transformation orchestrated by hepatocyte nuclear factor
4a (HNF4a) [23].
The adult mouse liver has served as an experimental paradigm
for tissue regeneration for decades. Surgical removal of 70% of the
liver mass, in a process termed partial hepatechtomy (PH), leads to
a coordinated cell cycle entry of hepatocytes in the remaining
lobes resulting in the compensatory outgrowth of a full-sized
functional liver. Genetic dissection in mice has identified the
importance of several members of the innate immune system in
the so-called priming phase of PH, including IL-6 and members of
the complement system. Disruption of IL-6, C3 and C5
significantly compromise or delay liver regeneration mainly by
blunting activation of the STAT3 pathway [24,25]. Signalling
through STAT3 is only transient and is in part down-regulated by
SOCS 3 (a target of STAT3) in a negative feed-back loop,
hypothesized to protect cells from prolonged cytokine signaling
[26]. The priming phase of PH ultimately drives hepatocytes into
active cell cycle with DNA synthesis peaking at 36–44 hours.
Here we set out to test the importance of the NMD component
UPF2 in a tissue of endodermal origin. Specifically, we use our
conditional UPF2 null mouse line to probe the functional role of
NMD at several stages of the ‘‘life cycle’’ of the liver, including
fetal development, adult life and in a regenerative setting. We find
that loss of UPF2 leads to activation of the DNA damage response
pathway in the developing liver and that UPF2 is essential for
development of a liver capable of sustaining postnatal life.
Disruption of UPF2 in the adult liver interferes with tissue
homeostasis and result in extensive liver damage. Finally, UPF2
null hepatocytes fail to enter active cell cycling following PH again
eluding to an important role for UPF2 in proliferating cells.
Results
Ablation of NMD in the developing liver leads to
perinatal lethality
Mice deficient of the core NMD component UPF2 die in utero
around E3.5-E7.5 [13]. In order to circumvent this early
embryonic lethality and to be able to probe the function of
NMD during the development of a defined organ, we crossed the
conditional Upf2
fl/+ allele onto the Alfp-Cre strain thereby
facilitating deletion of UPF2 during liver development. In the
Alfp-Cre line, expression of Cre recombinase is driven by regulatory
elements from both the albumin promoter and the Alfa-
fetoprotein enhancer, thereby leading to Cre expression in the
developing liver endoderm from around E10.0 [27].
Intercrosses between Upf2
fl/+; Alfp-Cre males and Upf2
fl/+
females yielded Upf2
fl/fl; Alfp-Cre fetuses in the expected frequen-
cies (1 in 8) at E13.5 (not shown), E16.5 and E18.5 (Figure 1C). In
contrast we only recovered 1.5% (2/137) Upf2
fl/fl; Alfp-Cre P0-P2
newborns demonstrating that liver-specific loss of UPF2, and by
inference NMD, leads to perinatal lethality (Figure 1C). When
genomic DNA from Upf2
fl/fl; Alfp-Cre fetuses was analyzed for
deletion of the floxed exons 2–3 of Upf2, we observed only partial
deletion (Figure 1A) accompanied with loss of full-length UPF2
protein and the appearance of a truncated non-functional isoform,
as reported earlier (Figure 1B) [13]. The partial recombination
that we observe in Upf2
fl/fl; Alfp-Cre embryos is due to the major
contribution of hematopoietic cells to the fetal liver mass at these
stages of development.
Loss of UPF2 was not accompanied by macroscopic changes in
liver attributes suggesting that UPF2 is not essential for the liver to
reach its final size (data not shown). Consistently, histological
analysis of E16.5 (Figure S1) and E18.5 (Figure 1D) did not reveal
any gross changes in tissue morphology in the Upf2
fl/fl; Alfp-Cre
fetal livers, however we did observe nuclei with abnormal
morphology at both these developmental stages. These abnormal
nuclei were present in frequencies of 0.6% and 1.1% of E18.5 and
E16.5 Upf2
fl/fl; Alfp-Cre fetal livers, respectively, and were not
found in sections from control littermates (Figure 1E). Moreover,
the hepatocyte origin of the cells with abnormal nuclei was
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(Figure 1D).
UPF2 deficient cells with abnormal nuclei are arrested in
mitosis
In order to further characterize the phenotype induced by liver-
specific loss of UPF2 during embryonic development, and in
particular the cells with abnormal nuclear morphology, we next
addressed the proliferative as well as the apoptotic status of fetal
liver cells of E16.5 and E18.5 embryos (Figure 2, Figure S1).
Consistent with the absence of loss of liver mass, both control and
UPF2 deficient embryos incorporated the S-Phase specific marker
BrdU to the same extent (Figure 2A). Similarly, the numbers of
pHH3 positive mitotic cells were identical for both control and
UPF2 deficient embryos (Figure 2B). However, a significant
fraction of pHH3 positive cells in UPF2 deficient fetal livers
displayed the abnormal nuclear morphology at both E16.5
(12%+/23%, data not shown) and E18.5 (13%+/24%,
Figure 2B, insert). Furthermore, all abnormal nuclei in UPF2
deficient fetal livers stained positive for the mitotic marker pHH3,
strongly suggesting that these cells are either arrested or at least
retarded in mitosis. Finally, we tested the possibility that the UPF2
deficient abnormal nuclear cells were lost by apoptosis. However,
TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end
labeling) staining failed to reveal evidence for apoptosis neither in
these cells, nor in the overall levels of apoptotic cells in UPF2
deficient livers (Figure 2C, Figure S1).
Collectively these findings demonstrate that loss of UPF2 during
fetal liver development leads to the appearance of cells arrested in
mitosis displaying abnormal nuclear morphology. However, the
loss UPF2 has no impact on overall proliferation or cellular
turnover.
Loss of UPF2 impairs the full development of the fetal
liver and leads to activation of the DNA Damage pathway
The appearance of nuclei with abnormal morphology does not
fully explain the perinatal lethality induced by liver-specific
ablation of UPF2. In order to address the cause of the perinatal
lethality in more detail, we subjected RNA from E16.5 and E18.5
fetal livers to global gene expression profiling. Comparison of the
Figure 1. Loss of UPF2 during fetal liver development. (A) Genotyping of embryos and newborns from intercrosses between Upf2
fl/+; Alfp-Cre
males and Upf2
fl/+ females. (B) Western blot analysis of UPF2 and a-tubulin immunoprecipitates from Upf2
fl/fl and Upf2
fl/fl; Alfp-Cre E16.5 embryos. (C)
Percentages of UPF2 null (defined as Upf2
fl/fl; Alfp-Cre) pups found at E16.5 (n=146), E18.5 (n=90) and P0-2 (n=137). (D) Histological analysis of
control (Upf2
fl/f) and UPF2 null (Upf2
fl/fl; Alfp-Cre) E18.5 fetal livers stained with HE (inset showing nuclei with abnormal morphology) or with an anti-
Albumin antibody (white arrow indicates a nucleus with abnormal morphology, see insert). (E) Quantification of nuclei with abnormal morphology at
E16.5 and E18.5 of control (Upf2
fl/f) and UPF2 null (Upf2
fl/fl; Alfp-Cre) fetal livers. The data represent quantification of at least 2000 cells from 3 different
individuals of each genotype at each of the two time points (mean +/2 standard deviation).
doi:10.1371/journal.pone.0011650.g001
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probesets at E16.5 and E18.5, respectively, which were deregu-
lated (fold changes .2o r,22; P,0.05) upon loss of UPF2 in
fetal liver cells (Figure 3A,B; Table S1 for full lists of deregulated
genes). Previously we have shown that loss of UPF2 in
hematopoietic cells leads to up-regulated expression of snoRNA
host genes, which is a class of transcripts that encodes snoRNA
mainly in their intervening introns [13]. Similarly to the case in
hematopoietic cells, a major fraction of the genes up-regulated in
UPF2 deficient livers at E16.5 and E18.5 were snoRNA host genes
(13 and 15 genes, respectively; See Tables S1,2), suggesting that
NMD is a major regulator of this pathway in several different cell
types.
As mice lacking HNF4a in the developing liver fail to undergo
terminal differentiation due to defects in epithelial transformation
we compared the expression of selected genes in our fetal UPF2
null livers to those reported in HNF4a null cells [23]. Consistent
with the normal morphology of the E18.5 UPF2 null livers, Hnf4a
and its downstream epithelial target genes Cdh1, Ceacam1, Gjb1 and
Gjb2 were either unchanged or marginally down-regulated in
UPF2 null livers (Table S3) These findings demonstrate that loss of
UPF2 interfere with liver development at a stage beyond the
HNF4a-dependent epithelial transformation.
We next subjected the E16.5 and E18.5 datasets to Gene Set
Enrichment Analysis (GSEA) with the aim to identify pathways
that were selectively deregulated by loss of UPF2 in fetal liver [28].
Intriguingly, gene sets representing ‘‘Liver-specific Genes’’ corre-
lated negatively with UPF2 null fetal livers demonstrating that loss
of UPF2 has a global effect on the development of the liver
(Figure 3D). Specifically a range of metabolic pathways, including
‘‘Fatty Acid Metabolism’’, ‘‘Valine Leucine and Isoleucine
metabolism’’, ‘‘Steroid Biosynthetic Process’’ and more were
down-regulated in UPF2 null fetal livers both at E16.5 and E18.5
(Figure 3C,D and Table S4 for the full analysis). In addition, we
noticed a decrease in the expression of genes belonging to
‘‘HSA04610 Complement and coagulation cascades’’ suggesting
that absence of NMD in the developing liver might influence the
function of this system (Figure 3C,D). GSEA also revealed
pathways in which the loss of NMD in fetal liver cells resulted in
an up-regulated expression of genes involved in mRNA processing
Figure 2. UPF2 loss during liver development does not affect proliferation, number of mitotic cells or apoptosis. (A) UPF2 null fetal
livers incorporate BrdU to similar extent as control livers. (B) UPF2 null fetal livers have similar number of mitotic cells as assayed by phosphorylation
of S10 of histone H3. Insert shows that nuclei with abnormal morphology are positive for pHH3. (C) TUNEL staining of UPF2 null and control fetal
livers. Inserts shows that nuclei with abnormal morphology are TUNEL-negative. The data represent quantification of at least 2000 cells from 3
different individuals of each genotype at each of the two time points (mean +/2 standard deviation).
doi:10.1371/journal.pone.0011650.g002
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(Figure 3C,D) which have previously been shown to be auto-
regulated via NMD [9,10,13,29]. These data are consistent with a
role of NMD in regulating splicing homeostasis.
Finally, GSEA also indicated that UPF2 deficient fetal livers up-
regulated transcripts induced by DNA damage (‘‘Response to
DNA damage stimulus’’ Figure 3C,D). An independent marker for
DNA damage is cH2AX, which is phosphorylated upon DNA
damage and accumulates at double-stranded DNA breaks. Indeed,
cH2AX-positive cells accumulated in UPF2 deficient livers at both
E16.5 and E18.5 demonstrating that loss of UPF2 activates the
DNA damage response pathway (Figure 3E,F).
In summary, our gene expression analysis indicates that ablation
of UPF2 during fetal organogenesis is incompatible with the
development of a metabolically functional competent liver able to
sustain postnatal life.
Ablation of NMD in adult quiescent liver disrupts liver
homeostasis
We next wanted to test if the NMD pathway is uniquely
important during fetal liver development or whether it also plays a
role during adulthood in a steady-state quiescent liver. To that end
we used the Mx1-Cre transgenic line in which Cre expression can
be induced by injection of mice with the double-stranded RNA
polyinosinic-polycytidylic acid (pIC), resulting in Cre-mediated
recombination mainly in liver and in hematopoietic cells [30]. In
order to circumvent the strong lethality induced by loss of UPF2 in
the hematopoietic compartment, we adopted an experimental
strategy where we generated chimeric mice by transplanting WT
bone marrow (BM) cells into lethally irradiated Upf2
fl/fl control
and Upf2
fl/fl; Mx1Cre experimental animals [13] and, following
reconstitution of the hematopoietic system, induced loss of UPF2
in liver cells by injection with pIC (Figure 4A). Although this
strategy efficiently rescues mice from the early hematopoietic
associated lethality (median survival time =6 days, [13]), they did
become moribund after 3 weeks suggesting a crucial role of UPF2
in the adult liver (Figure 4B and data not shown). Analysis of
UPF2 null livers 21 days post pIC revealed efficient excision at the
Upf2 locus resulting in the expression of the truncated non-
functional form of UPF2, as reported previously (Figure 4C,D;
[13]). This was accompanied by strong disorganization of the liver
tissue and by the induction of hepatic steatosis as evidenced by
accumulation of lipids in Upf2 null livers (Figure 4E). Further
evidence supporting the notion that loss of UPF2 leads to liver
damage comes from analysis of serum from UPF2 null mice 21
days post pIC injection. Here, loss of UPF2 resulted in highly
elevated serum levels of markers of liver damage including Alanine
Aminotransferase (ALAT), Aspartate Aminotransferase (ASAT)
and Lactate Dehydrogenase (LDH) activites, accompanied by low
glucose levels, increased triglyceride values and highly elevated
levels of bilirubin (Figure 4F). Surprisingly, but consistent with the
data from the fetal liver system, loss of UPF2 did not lead to any
appreciable cell death as assayed by TUNEL staining (Figure S2).
Moreover, and in contrast to the effects in fetal liver, we were
unable to detect any induction of DNA damage upon deletion of
UPF2 in the adult liver (data not shown). These data demonstrate
that UPF2, and by inference the NMD system, is essential for
maintenance of liver homeostasis and that liver-specific loss of
UPF2 leads to pronounced liver damage and death within a
month after its deletion.
Having demonstrated that loss of UPF2 in the adult liver leads
to liver damage, we next used gene expression profiling to probe
the underlying cause. In order to avoid putative secondary effects
caused by extensive tissue damage and invasion of WT immune
cells observed at 21 days post deletion, we harvested livers from
pIC injected BM transplanted Upf2
fl/fl control and Upf2
fl/fl;
Mx1Cre experimental animals 14 days after initiating deletion of
UPF2 (Figure 5A). At this time point livers from pIC injected
Upf2
fl/fl; Mx1Cre mice were fully recombined (Figure 5B), appeared
essentially normal as assessed by histology (Figure 6B) and
displayed no signs of infiltrating immune cells (Figure 5B). Gene
expression profiling of RNA harvested from 14 days post deletion
livers identified 1486 up-regulated (fold change .1.5; P,0.001)
and 981 down-regulated probesets (fold change ,21.5; ,0.001;
Figure 5C,D; See Table S5 for full gene list). Again, we observed
that loss of UPF2 leads to the up-regulation of 37 snoRNA host
gene transcripts and that these transcripts are among the most up-
regulated (Figure 5E, Table S2). As it has been demonstrated that
NMD features may lead to nonsense-mediated transcriptional
gene silencing (NMTGS), we next tested whether snoRNA host
genes were transcribed at lower rates in UPF2 null livers [31].
Chromatin immunoprecipitation followed by qPCR (qChIP)
showed that the gene bodies of 6 up-regulated snoRNA host
genes were occupied by RNA polymerase II to the same degree in
both WT and UPF2 null livers, suggesting that they are transcribed
at similar rates in both genotypes (Figure 5F). Hence, these
findings argues against a role of NMTGS in down-regulation of
mature snoRNA host gene transcripts and demonstrate that these
transcripts are indeed direct targets of the NMD machinery.
Similar to what we found in the fetal liver, GSEA (See Table S6
for the full analysis) revealed that loss of UPF2 in the adult setting
led to down-regulation of genes involved in ‘‘HSA04610
Complement and Coagulation cascades’’ and metabolic pathways
as exemplified by ‘‘Biosynthesis of Steroids’’ albeit at less
significance as what resulted from embryonic loss of UPF2
(Figure 5G). Quantitative RT-PCR confirmed deregulation of
these pathways (Figure 5H) and functional assessment of the
complement system revealed a pronounced reduction in the
activities of both the classical and alternative pathways in UPF2
null sera (Figure 5I, Figure S3). These findings demonstrate that
Figure 3. Gene expression analysis of control and UPF2 null fetal livers. (A) Cluster analysis of normalized affymetrix expression data from
control and UPF2 null E18.5 fetal livers. (B) Summaries of deregulated probesets at E16.5 and E18.5 in control vs UPF2 null fetal livers. (C) qRT-PCR
validation of deregulated genes belonging to different functional classes in E18.5 UPF2 null fetal livers. Red and blue colors indicate up-regulated and
down-regulated genes, respectively, in UPF2 null fetal livers. cDNA was synthesized from 3 mice of each genotype and assayed by qPCR in triplicates
(mean +/2 standard deviation). (D) Selected enriched gene sets from GSEA analysis. D1-D2: HSIAO_Liver_Specific_Genes, D3: Fatty_Acid Metabolism,
D4: HSA04610_Complement_And_Coagulation_Cascades, D5: mRNA_Processing_Reactome, D6: Response_to_DNA_Damage_Stimulus. Normalized
enrichment scores, p-value and q-values (FDR) are indicated for each gene set. Negative and positive NES values indicate enrichment in control and
UPF2 null fetal livers, respectively. Y-axes indicate Enrichment scores (top) and Ranked list metric (bottom). Green lines indicate enrichment profile,
black bars are hits (i.e. genes) and grey profiles are ranked metric score. Red and blue indicate positive and negative correlations, respectively, with
the indicated gene sets. (E) Immunofluorescence analysis of control and UPF2 null fetal livers demonstrate the accumulation of nuclei positive for the
DNA Damage marker cH2AX upon loss of UPF2. Insert shows a close-up on two nuclei with abnormal morphology, one of them being positive for
cH2AX. (F) Quantification of the data in (E). The data represent quantification of at least 2000 cells from 3 different individuals of each genotype at
each of the two time points (mean +/2 standard deviation).
doi:10.1371/journal.pone.0011650.g003
The In Vivo Role of NMD
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11650The In Vivo Role of NMD
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11650hepatocytes require UPF2 for the generation of an efficient
complement system.
GSEA also revealed similarity between fetal and adult livers
among the gene sets for which expression correlated positively
with loss of UPF2. Here, although no gene sets fell below our
false discovery cut-off of 0.05, we did observe borderline up-
regulation of gene sets in ‘‘mRNA processing reactome’’ and in
the ‘‘Regulation of Mitosis’’ a n dw ew e r ea b l et ov a l i d a t et h e
up-regulation of several of the leading edge transcripts by qRT-
PCR (Figure 5G,H). As reported above, we could not detect
any evidence for the induction of a DNA damage response
above background in the adult UPF2 null livers – a finding
entirely consistent with the failure of gene sets representing
DNA damage to approach our significance cut-offs (data not
shown).
Finally, we tested to what extent loss of UPF2 lead to the
stabilization of known PTC+ mRNA isoforms derived from AS-
NMD [9,13]. Consistent with our previous findings in the
hematopoietic system, loss of NMD promoted an increase in the
relative abundance of the PTC+ isoform for 9/9 tested transcripts
(Figure S4).
In summary, our findings demonstrate the vital importance of
UPF2, and by inference NMD, in maintaining homeostasis of the
adult liver.
UPF2 deficient livers fail to regenerate following partial
hepatectomy
We have previously demonstrated that deletion of UPF2 in the
hematopoietic system led to a pronounced depletion of cycling
progenitor cells in the BM ultimately resulting in BM failure [13].
In addition, UPF2 deleted lymphocytes were unable to enter the
cell cycle upon stimulation, suggesting that UPF2 is required for
active proliferating cells.
We took advantage of the regenerative power of the
hepatectomized liver to test whether the loss of UPF2 was
compatible with efficient regeneration. Specifically, we performed
a 70% hepatectomy on BM transplanted Upf2
fl/fl control and
Upf2
fl/fl; Mx1Cre mice two weeks after pIC injection and these mice
were subsequently sacrificed 36 hours after surgery (Figure 6A). In
contrast to control mice (BM transplanted Upf2
fl/fl), PH in BM
transplanted Upf2
fl/fl; Mx1Cre mice was associated with a
substantial post-surgery mortality (.50%), most likely reflecting
the massive changes in the transcriptome of UPF2 deficient livers.
Immunofluorescence assessment of PCNA and Ki67 – both
markers of actively cycling cells – revealed a marked difference
between control and UPF2 null hepatocytes (Figure 6C,D, Figure
S5). Whereas the former efficiently entered the cell cycle reaching
a level of 32% PCNA positive nuclei 36 hours post PH, UPF2
deleted hepatocytes were essentially deficient in sustaining liver
regeneration as assayed by both Ki67 and PCNA staining. Jointly,
these data, and those from the hematopoietic system, unambig-
uously demonstrate that UPF2 is absolutely required for
proliferating cells in both these tissues under relevant physiological
conditions.
Liver-specific loss of UPF2 interferes with the induction of
a transcriptional program necessary for liver regeneration
UPF2 null hepatocytes are unable to re-enter the cell cycle
following PH. In order to get insights into the underlying
molecular cause for this phenotype, we next compared the gene
expression changes induced by PH in control and UPF2 deficient
livers. We adopted a similar protocol as described above in which
BM transplanted Upf2
fl/fl control and Upf2
fl/fl; Mx1Cre mice were
subjected to PH two weeks after pIC injection. Comparison of the
gene expression profiles of control mice at surgery (0 hours) and
36 hours post-surgery revealed a massive transcriptional repro-
gramming induced by PH with 2123 probesets displaying
significant changes (fold changes .1.5 or ,21.5; P,0.05,
Figure 7A,B; See Table S7). PH of BM transplanted Upf2
fl/fl;
Mx1Cre animals also led to a pronounced transcriptional
reprogramming with 1924 probesets (fold changes .1.5 or
,21.5; P,0.05) being changed when the 0 hours and 36 hours
timepoints were compared. Despite the massive transcriptional
reprogramming that occurs in both genotypes, only a limited
fraction of the changes are shared by control and mutant livers
(Figure 7B). Among the down-regulated probesets 29–32% (360/
1233 in control and 360/1121 in mutant) are common for the two
genotypes, whereas the corresponding fraction for up-regulated
probesets are as low 13–15% (120/900 in control and 120/803 in
mutant).
We next employed GSEA on the 4 data sets (up and down-
regulated genes for each of the two genotypes) with the aim to
identify gene programs specific for the two genotypes. Entirely
consistent with the phenotypic data, we found that whereas control
livers up-regulate a series of gene sets associated with active cell
cycle (e.g. ‘‘Serum_Fibroblast_CellCycle’’ in Figure 7C, See Table
S8 for full analysis) following PH, UPF2 deficient livers fail to do
so. Actually, PH following loss of UPF2 appears to lead to a
further withdrawal from the cell cycle as suggested by the down-
regulation of gene sets associated with active cell cycle (Figure 7C).
We validated these findings by qRT-PCR on four cell cycle
regulated and PH-induced transcripts (Ccnd1, CcnE2, Mcm2,
CcnA2) and found that all four are induced in control mice and
down-regulated in animals lacking UPF2 in the liver (Figure 7D).
The finding that none of these four transcripts are induced in
mutant livers even at 48 hours after surgery argues against a
delayed cell cycle entry caused by loss of UPF2.
GSEA further showed that whereas PH in control livers induced
a dedifferentiation program at 36 hours as evidenced by down-
regulation of metabolic and catabolic gene sets (as exemplified by
‘‘HSA001000_Biosynthesis_of_steroids’’ and HSA00280_Valine_-
Leucine_and_Isoleucine_Degradation in Figure 7E), none of these
gene sets were significantly enriched in UPF2 deficient livers
(Table S8). In contrast, UPF2 deficient livers respond to PH by up-
regulating gene sets associated with proteasome and ribosome
function (as exemplified by ‘‘HSA03050_Proteasome’’ and
‘‘Structural_Constituent_Of_Ribosome’’ (Figure 7E)) perhaps
reflecting a stage where the regenerating liver is preparing for
increased cellular turnover. Furthermore, the similar levels of Socs3
Figure 4. UPF2 is essential for homeostasis of the adult liver. (A) Experimental strategy for the induction of UPF2 loss in the adult liver of BM
transplanted control (Upf2
fl/fl) and Upf2
fl/fl;Mx1Cre mice. (B) BM transplantation rescues the lethality of Upf2
fl/fl;Mx1Cre mice. (C) Genotyping of BM
transplanted (control and UPF2 null mice 3 weeks after the first pIC injection demonstrates efficient deletion in liver. UPF2 null adult livers also
accumulate WT (+) cells of hematopoietic origin. (D) Western blot analysis of UPF2 and a-tubulin immunoprecipitates from control and UPF2 null
adult livers. (E) Histological analysis using either immunohistochemistry of immunofluorescence techniques demonstrated loss in tissue organization
(HE and b-catenin) and accumulation of lipids (Oil Red O) upon loss of UPF2 in adult liver. (F) Serum analysis of control and UPF2 null adult livers
shows the accumulation of markers for liver damage (ALAT, ASAT, LDH and bilirubin), lowered glucose levels and triglyceride accumulation. The data
represent the average of .8 mice in each group (mean +/2 standard deviation).
doi:10.1371/journal.pone.0011650.g004
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11650Figure 5. Gene expression analysis of UPF2-deficient adult livers. (A) Experimental strategy for the induction of UPF2 loss in the adult liver of
BM transplanted control (Upf2
fl/fl) and Upf2
fl/fl; Mx1Cre mice. (B) Genotyping of control and UPF2 null mice 2 weeks after the first pIC injection
demonstrates efficient deletion in liver. (C) Summaries of deregulated probesets in control and UPF2 null adult livers. (D) Cluster analysis of
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PH, suggest that activation of the STAT pathway during the
priming phase of PH has occurred normally in mutant livers
(Table S3). Similarly, the expression of both Cebpa and Cebpb, two
transcription factors repressed and induced, respectively, during
the priming phase of PH, also appear comparable in control and
UPF2 null livers.
Collectively our analysis of the transcriptional response to PH
reveals that lack of UPF2 leads to a block in liver regeneration at a
stage before dedifferentiation and entry into the cell cycle and
further underlines the strong requirement for UPF2 in prolifer-
ating cells.
Discussion
The NMD pathway is a critical posttranscriptional pathway
regulating mRNA stability by its ability to find and destroy PTC+
mRNAs. NMD targets are highly divergent, both in terms of
functional classes, but also due to their poor lack of evolutionary
conservation. Thus there is an urgent need to develop appropriate
experimental models that allow us to test the functional role of
NMD in mammalian systems relevant for human biology and
disease.
Here we report on the first in vivo characterization of the
importance of RNA surveillance at several stages of the life cycle of
the liver including development, homeostasis and regeneration.
The present data demonstrate that loss of UPF2, and by inference
NMD, affects all these stages through several distinct mechanisms.
NMD and Liver function
During embryonic development the fetal liver plays pivotal roles
both in the preparation for postnatal life but also as the primary
hematopoietic organ in utero. Loss of UPF2, initiated from the early
stages of hepatoblast migration and onwards, resulted in relative
minor phenotypes, the main being the lack of terminal
differentiation of fetal liver cells at a stage beyond the HNF4a-
dependent epithelial transformation. The inability of UPF2 null
fetal livers to undergo terminal differentiation was incompatible
with postnatal life. The relatively normal fetal liver development of
UPF2 null livers is further supported by the lack of anemia in these
embryos (data not shown), which would be predicted if the liver
experienced gross developmental abnormalities. A formal possi-
bility for the mild phenotype could be partial hepatoblast-specific
deletion of UPF2. However, this is not consistent with our gene
expression analysis demonstrating down-regulation of several
transcripts to background levels (Table S1).
In contrast to the relatively minor phenotype of UPF2 null fetal
livers, induced loss of UPF2 is highly detrimental to a steady-state
adult liver. Thus, within 3 weeks post deletion the liver has
deteriorated functionally as evidenced by down-regulation of
metabolic transcriptional programs, hepatosteatosis and signs of
liver damage. This is accompanied by hepatosteatosis, i.e.
accumulation of lipids in the liver, presumably caused by a
reduced capacity of the organ to metabolize lipids. The functional
deterioration of the liver, which is also evidenced by increased
serum levels of bilirubin, occurs in the absence of detectable
apoptosis. Furthermore, when UPF2 null liver is subjected to PH
two weeks post deletion, hepatocytes arrest at a stage past the
priming phase but prior to entering active cell cycle.
Gene expression analysis before and after PH show that UPF2
null mice induce a transcriptional program that overlap only
partially with the one induced in WT mice and suggest that the
NMD pathway may modulate central components required for
regeneration. Interestingly, loss of UPF2 leads to a selective down-
regulation of transcripts associated with complement activity
including C1S, C2 and C8B in both fetal and in steady state adult
liver; and importantly, that this down-regulation was associated
with reductions in both the classical and alternative complement
pathways. This result is particular intriguing in light of the inability
of livers deficient for the complement factors C3 or C5 to
regenerate in response to PH [25]. Thus, down-regulation of
complement activity, along with the requirement of NMD for
active cell cycling (see below), suggest molecular mechanisms by
which regeneration is blocked in UPF2 deficient mice.
NMD and the Cell cycle
Tissue-culture studies have previously implicated NMD factors
in cell cycle progression in mammalian cells. These include UPF1,
SMG1 and SMG6, whereas UPF2 was reported to be dispensable
[12,18,19]. The latter result contrast findings from Drosophila cell
lines and our own analysis of UPF2 deficient lymphocytes where
loss of UPF2 in both cases interfered with cellular proliferation
[13,32]. Consistently, we find that deletion of UPF2 results in a
complete lack of recruitment into active cell cycling following PH.
At present, we have not pinpointed the cell cycle defects to any
distinct phase of the cell cycle, however, preliminary data from
UPF2 null lymphocytes suggest that loss of NMD in these cells
results in an early block in S-phase (JW and BTP, unpublished
observations). UPF2 null fetal livers also display a phenotype
consistent with defects in normal cell cycle progression, albeit not
to the same extent as during PH, with accumulation of abnormal
mitotic cells. Furthermore, the accumulation of a marker for
double-stranded DNA breaks in UPF2 null hepatoblast is
compatible with problems transversing the S-phase in these mice.
This notion is further corroborated by the fact that regenerating
UPF2 null adult hepatocytes, which are completely unable to
proliferate, also lack any detectable activation of DNA damage
normalized affymetrix expression data from control and UPF2 null adult livers. (E) Distribution of snoRNA host genes (defined as genes having intron-
encoded snoRNAs) among up and down-regulated genes. 0–20, 20–40 etc. indicates percentiles within up and down-regulated probesets. Thus, 0–20
indicates the top 20% of up and down-regulated genes. (F) ChIP analysis of RNA Pol2 occupancy of selected snoRNA host genes. Enrichment values
are given relative to Actb (normalized to a gene dessert). Expression fold changes (all up in UPF2 null livers) derived from affymetrix gene expression
profiling are shown in red above each gene. Immunoprecipitates were performed on two mice of each genotype and assayed by qPCR in triplicates
(mean +/2 standard deviation). (G) Selected enriched gene sets from GSEA analysis. G1: HSA04610_Complement_And_Coagulation_Cascades, G2:
Biosynthesis_of_steroids, G3: mRNA_Processing_Reactome, G4: Regulation_of_mitosis. Normalized enrichment scores, p-value and q-values (FDR) are
indicated for each gene set. Negative and positive NES values indicate enrichment in control and UPF2 null adult livers, respectively. Y-axes indicate
Enrichment scores (top) and Ranked list metric (bottom). Green lines indicate enrichment profile, black bars are hits (i.e. genes) and grey profiles are
ranked metric score. Red and blue indicate positive and negative correlations, respectively, with the indicated gene sets. (H) qRT-PCR validation of
deregulated genes belonging to different functional classes in adult UPF2 null livers. ‘‘Non-protein’’ indicates SnoRNA host genes. Red and blue colors
indicate up-regulated and down-regulated genes, respectively, in UPF2 null adult livers. cDNA was synthesized from 3 mice of each genotype and
assayed by qPCR in triplicates (mean +/2 standard deviation). (I) Functional assessment of the classical and alternative complement pathways in
control and UPF2 null adult sera. The data represent the average of 3 experiments each involving 5–7 mice of each genotype (mean +/2 standard
deviation).
doi:10.1371/journal.pone.0011650.g005
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proliferation. In any event, our findings further reinforce the
requirement of NMD components, including UPF2, for active
proliferation in mammalian cells although our data from the fetal
liver shows that there are important cell type- and/or develop-
mental-specific differences. As loss of several individual NMD
components in tissue-culture converge at blocking cell cycle
progression, this most likely reflects the activity of the NMD
Figure 6. UPF2 is essential for liver regeneration. (A) Experimental strategy for the induction of UPF2 loss in the adult liver of BM transplanted
control (Upf2
fl/fl) and Upf2
fl/fl; Mx1Cre mice followed by PH. (B) Immunofluorescence analysis of b-catenin of control and UPF2 null adult livers 14 days
after the first pIC injection. (C) Immunofluorescence analysis of PCNA expression before (0 h) or after (36 h) PH. (D) Quantification of the data from (C),
representing the average of three mice of each genotype at each time point. 200–500 nuclei were counted for each mouse at each time point (mean
+/2 standard deviation).
doi:10.1371/journal.pone.0011650.g006
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PLoS ONE | www.plosone.org 11 July 2010 | Volume 5 | Issue 7 | e11650Figure 7. Gene expression analysis of UPF2 null adult livers following PH. (A) Cluster analysis of normalized affymetrix expression data from
control and UPF2 null adult livers before (0 h) or after (36 h) PH. Venn diagrams of differentially expressed probesets following PH. The diagrams
reveals the induction of partially overlapping gene expression programs in control and UPF2 null adult livers following PH. (C) GSEA reveals that gene
sets involved in cell cycle regulation are differentially induced in control and UPF2 null adult liver following PH. (D) qRT-PCR validation of 4 cell cycle
regulated and PH-induced genes. cDNA was synthesized from 3 mice of each genotype at each timepoint and assayed by qPCR in triplicates (mean
+/2 standard deviation). (E) Selected enriched gene sets from GSEA analysis of differentially expressed genes following PH in control and UPF2 null
livers. E1: HSA00100_Biosynthesis_of_Steroids, E2: HSA00280_Valine_and_Isoleucine_degradation, E3: HSA03050_Proteasome, E4: Structural_
Constituent_of_ribosome. Normalized enrichment scores, P-value and q-values (FDR) are indicated for each gene set. Negative and positive NES
values indicate enrichment in control and UPF2 null adult livers, respectively. Y-axes indicate Enrichment scores (top) and Ranked list metric (bottom).
Green lines indicate enrichment profile, black bars are hits (i.e. genes) and grey profiles are ranked metric score. Red and blue indicate positive and
negative correlations, respectively, with the indicated gene sets.
doi:10.1371/journal.pone.0011650.g007
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members. This view is consistent with recent studies from
zebrafish, where knockdown of individual NMD components
yielded highly similar phenotypes suggesting that they are
conferred by ablation of NMD function as such [33].
As the NMD pathway affects both mRNA isoform distributions
as well as transcript levels, unraveling the underlying molecular
mechanism(s) for the NMD requirement in proliferation will
require full whole-transcriptome mapping studies of NMD
deficient mammalian cells as well as the development of a
conditional NMD null cell system amenable to rescue experiments.
Such experiments are currently underway.
NMD and gene regulation
The NMD pathway regulates two main classes of transcripts:
The first class encompasses transcripts, which have undergone
erroneous processing leading to the generation of translatable
PTC+ variants fulfilling the molecular rules of NMD. The second
class of transcripts is non-erroneous and gives rise to NMD by a
variety of mechanisms [12,13,34]. For these transcripts, NMD
serves as an important posttranscriptional regulator of transcript
levels.
Our gene set enrichment analysis suggested that NMD is
essential for the proper regulation of selected transcript classes. In
particular, we find that transcripts belonging to the ‘‘mRNA
processing’’ category, including regulators of splicing, are
significantly up-regulated upon loss of UPF2. This is particular
intriguing in light of the established role of NMD in setting up
autoregulatory loops through AS-NMD. Hence our data suggest
that disturbing these feedback mechanisms lead to the deregula-
tion of transcript levels of a subset of these factors, perhaps through
expression of dominant negative variants. As splice site selection is
believed to be controlled by a competition between positive and
negative regulators, such as SR (Serine-Arginine rich) and hnRNP
proteins [35,36], changing the relative levels of these splicing
modulators may have profound overall consequences for global
splicing patterns. Future whole-transcriptome experiments of
relevant UPF2 deficient tissues will formally test this possibility.
SnoRNA host genes constitute a diverse class of transcripts
which harbor snoRNA genes within their intronic sequences [37].
SnoRNA coding sequences can reside in either protein coding
genes or in pseudogenes, which have lost their protein coding
potential while maintaining their exon-intron structures, perhaps
to facilitate efficient snoRNA expression. These small RNAs are
involved in guiding functional important posttranscriptional
modifications of cellular RNAs, mainly rRNAs, and are therefore
often abundantly expressed. Here we show that more than 40
snoRNA host genes are regulated by NMD in at least one tissue.
Furthermore, as loss of NMD does not result in any differences in
RNA Polymerase II occupancy for 6/6 tested highly up-regulated
snoRNA host genes, our data imply that snoRNA host genes are
normally efficiently degraded in the presence of a functional NMD
pathway. We conclude that NMD has evolved as an efficient
regulator of snoRNA metabolism perhaps to allow the abundant
expression of a subset of these RNAs.
In addition to the more special cases of splicing regulators and
snoRNA host genes, the NMD pathway also regulate a range of
other transcripts. There may be several reasons as to why the cell
chooses to express transcripts with obvious NMD features such as
uORFs and introns within the 39UTR. One possible explanation
is offered by the observation that NMD occurs with different
efficiencies in different cell types and may therefore be involved in
generating tissue-specific expression patterns, in a manner
reminiscent of miRNAs [14]. It also remains possible that NMD
efficiency could be regulated by intra- and extracellular cues,
perhaps through posttranscriptional modifications of key NMD
factors. This would allow the cell to either up-regulate or down-
regulate the transcript levels of NMD targets in response to
different stimuli. These two possibilities do by no means exclude
each other.
In summary, our data provides novel insights into the
importance of RNA surveillance in general, and NMD in
particular, for mammalian biology. We have shown that the loss
of NMD at different phases of the life cycle of the liver has distinct
phenotypic consequences, suggesting that NMD plays multiple
roles in liver function. These include differential requirements for
NMD in proliferating cells, regulation of distinct transcript classes
as well as more systemic effects on alternative splicing. As different
cell types may have different needs, our studies together with those
from our previous analysis of the hematopoietic system [13],
highlights the importance of characterizing general systems, such
as the NMD pathway, in several different tissues.
Materials and Methods
Ethics statement
All mouse work was performed according to national and
international guidelines and approved by the Danish Animal
Ethical Committee. This study was approved by the review board
at the Faculty of Health, University of Copenhagen (LT-P0658).
Mice strains and Procedures
The generation and genotyping of UPF2 conditional knockout
mouse has been reported previously [13]. The conditional Upf2
fl/+
allele was crossed onto the tissue-specific Alfp-Cre [27] and Mx1-
Cre [30] deleter strains. All experimental animals had been
backcrossed to the C57/B6 background for at least six
generations.
For the fetal liver knockout of UPF2, Upf2
fl/+; Alfp-Cre males
were crossed with Upf2
fl/+ females and embryos were harvested
from pregnant females at E13.5, E16.5 and E18.5. For
determination of fetal liver proliferation, pregnant females
received a single intraperitoneal injection of 5-bromo-2-deoxyur-
idine (100 mg BrdU/g body weight; Sigma) prior to sacrifice. The
sex of the embryos was determined using primers specific for the
Sry gene located at the Y chromosome. For the generation of the
adult liver-specific knockout of UPF2, 10–12 weeks old female
Upf2
fl/fl and Upf2
fl/fl; Mx1Cre animals (CD45.2) were lethally
irradiated by a single radiation dose (900 cGY) and transplanted
with 5 million BM cells from CD45.1 C57/B6. Six weeks after
transplantation recipient mice were injected 3 times (Day 0, Day 2
and Day 4) with pIC (300 mg, GE Healthcare). Mice were either
sacrificed (at day 14 or day 21) or subjected to PH.
Partial hepatectomy was performed by removal of 70% of the
liver mass (i.e. the median and left lateral lobes) under Isoflurane
inhalation anaesthesia. A midline abdominal skin and muscle
incision of 1.5 cm was used to expose the Xiphoid process. The
lobes were tied off separately and excised while keeping the gall
bladder and suprahepatic vena cava intact. Subsequently, the
peritoneum and the skin were sutured and the animals left to
recover. Hepatectomized animals were sacrificed at 36 hours,
48 hours or 72 hours after the procedure.
Immunohistochemistry and immunofluorescence
microscopy
Livers were harvested, washed in PBS and subjected to four
overnight incubations at 4uC. Day 1 in 4% PFA, day 2 in 30%
sucrose, day 3 in 1:1 mix of 30% sucrose and OCT (VWR), day 4
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cryomolds and stored at -80uC. Livers were cryo-sectioned (6–
8 mm) onto Tonto SuperFrostH microscope slides (VWR) and
stored at 280uC. Antigen retrieval was obtained by boiling in
0.01 M, pH 6.0 citrate buffer for 10 min. followed by cooling to
room temperature. Slides were blocked with 5% BSA in PBS and
subsequently stained with primary mouse monoclonal antibodies
against Ki67 (clone B56; BD Biosciences Pharmingen, San Jose,
CA, USA), PCNA (clone PC10; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), b-catenin (clone 14; Transduction laboratories,
Lexington, Kentucky, USA) phospho-S139-cH2AX (clone
JBW301; Millipore), BrdU (clone Bu20a, DAKO) or rabbit
polyclonal antibodies against phosho-Ser10-HH3 (Millipore) and
Albumin (DAKO, Copenhagen, Denmark) over night at 4uC.
Slides were the incubated with relevant secondary antibodies for
1 hour, i.e. either secondary goat-anti-mouse Alexa FluorH 594 or
goat-anti-rabbit Alexa FluorH 594 antibodies (Invitrogen, Eugene,
Oregon, USA) or using the Envision+ system (Dako, Denmark)
according to the manufacturers instructions. Nuclei were stained
with DAPI (Invitrogen) at 1 mg/mL for 5 min. Sections were
examined using either a Zeiss Axioplan2 imaging fluorescence
microscope, a Leica TCS SP2 confocal microscope, or a Olympus
BX51d microscope.
Hematoxylin-eosin (HE) staining of fetal and adult liver sections
was performed as described previously [38]. For the staining of
livers for accumulation of lipids fixed slides was incubated 8 min.
in pre-warmed (60uC) Oil Red O solution (0.5% in propylene
glycol), destained 265 min in propylene glycol and rinsed twice in
water. TUNEL (Terminal deoxynucleotidyl transferase-mediated
biotinylated UTP nick end labeling) was performed using an In situ
Cell Death Detection Kit (Roche) according to the manufacturers
instructions.
Immunoprecipitation
Liver lysates were prepared by homogenizing liver in ice-cold
RIPA buffer (20 mM Tris-HCl, pH 7.2, 1% sodium deoxycholate,
1% Triton X-100, 0.1% SDS, 150 mM NaCl plus 2 mM PMSF,
2 mg/mL aprotinin, 2 mg/mL leupeptin) with a loose-pestle
Dounce homogenizer on ice for 10 min, resulting in a 50% (w/
w) liver homogenate. The homogenates were incubated on ice for
30 min and clarified by centrifugation (14,0006g; 30 min; 4uC)
and the resulting lysates were used immediately or stored at
280uC.
To immunoprecipitate UPF2, the lysates were incubated with
Protein G agarose-bound affinity purified rabbit anti-UPF2
polyclonal antibody (the antibody was a kind gift from Dr Jens
Lykke-Andersen) by rotating at 4uC overnight. Next, the UPF2-
bound agarose slurry was spun down and the supernatant was
used to precipitate alpha-Tubulin, using mouse monoclonal anti-
Tubulin antibody (T9026, Sigma) bound to Protein A/G. After
binding, the protein-bound slurries were washed three times,
resuspended in 26SDS Loading buffer and boiled. Proteins were
separated by SDS-PAGE followed by Western blotting, using a
Mini-Trans Blot Electrophoretic Transfer Cell (BioRad).
Chromatin immunoprecipitation
Livers were harvested, directly snap-frozen in liquid nitrogen
and stored at 280uC. After thawing, tissue samples were
homogenized by douncing (loose pestle, Wheaton 15 ml douncer)
in cold PBS, and cross-linked for 10 min. in 1% formaldehyde
using a rotator. ChIP was performed using 30 mg chromatin to
2 ml of POL-II subunit B1 antibody (AC-055-100, Diagenode)
with washing steps and DNA retrieval as described previously
[39]. Enrichment ratios were examined by qPCR (ABI Prism
7000) with primer sets directed against internal gene body
positions of the indicated genes versus a negative position at a
gene desert on chromosome 12. Data are given as enrichment
ratios normalized to the negative detector and further expressed
relative to those of Actb.
Quantitative RT-PCR analysis
cDNA was synthesized using Protoscript First Strand cDNA
Synthesis Kit (New England Biolabs), according to manufacturer’s
instructions. Briefly, oligo dT primer was used to prime first-strand
cDNA synthesis from 0.5 ug of total RNA using dNTP mix, 16
RT Buffer, RNase inhibitor and M-MuLV Reverse Transcriptase
at 42uC for 1 h. Finally, the RNA templates were degraded, by
treating with RNase H at 37uC for 20 min.
The single-stranded cDNA was diluted 1:10 and analyzed by
qPCR using 0.3 mM primers (see Table S9 for list of primers), with
Maxima SYBR Green qPCR Master Mix (Fermentas), as
described by the manufacturer. The qPCR was run on a 7000
Sequence Detection System (Applied Biosystems) and analyzed
with the accompanying software. Expression values are normal-
ized to Rrpo.
For the detection of alternative splicing, cDNA was used as
template for standard PCR reactions using primers against
selected mRNA isoforms (Table S9).
Serum analysis
Peripheral blood was collected into Microtainer tubes contain-
ing lithium heparin gel (BD). Samples were spun down at 2000 g
for 10 min. after which serum was collected into clean eppendorf
tubes and stored at 220uC. Samples were analyzed on a Modular
(Roche Diagnostics).
Complement activity
Peripheral blood was allowed to clot for 20 min. at room
temperature, followed by 15 min. incubation on ice and
centrifugation for 15 min. at 7500 g. Serum was withdrawn and
stored at 280uC. Activity of the classical pathway was determined
from C3 deposition on K562 cells (ATCC, LGC Promochem,
Boras, Sweden) opsonised with affinity-purified rabbit polyclonal
antibodies raised against K562 cells. Briefly, K562 cells were
washed twice in cold PBS and 500,000 cells were added to
reaction tubes containing PBS with 2 mM MgCl2, 0.15 mM
CaCl2, 5 mg/ml of antibodies and 10% mouse sera in a total
volume of 50 ml. After 30 min incubation at 37uC cells were
washed with cold PBS with 1% fetal calf serum. The amount of
deposited C3b was measured using FITC-conjugated goat anti-
mouse C3 (ICN/MP Biomedicals, Illkirch, France) diluted 1:100
and allowed to bind for 1 h at 4uC. The cells were washed three
times with cold PBS with 1% fetal calf serum and analyzed by flow
cytometry. Activity of the alternative pathway was determined
using a hemolytic assay of rabbit erythrocytes [40].
RNA isolation and gene expression profiling
Livers were snap-frozen in liquid nitrogen immediately after
harvest. Small tissue slices were homogenized in Trizol using a
Pellet Pestle Motor (Kontes). Total RNA was isolated according to
the manufactures protocol (Invitrogen).
Two independent microarray analyses were performed using
fetal liver and adult liver (before and after PH). RNA samples were
labeled as described previously [13] and hybridized to the Mouse
Genome 430 2.0 GeneChip (Affymetrix, Santa Clara, CA, USA).
Cel files were imported into the statistical software package R v.
2.7.2 using BioConductor [41] and gcRMA modeled using
The In Vivo Role of NMD
PLoS ONE | www.plosone.org 14 July 2010 | Volume 5 | Issue 7 | e11650quantiles normalization and ‘‘lowess’’ summarization [42].
Detection calls were determined by the MAS 5.0 algorithm
implemented in the Bioconductor package affy (100% present calls
required within each replicate group) and the modeled log-
intensities of the probe sets were used for high-level analysis of
selecting differentially expressed genes.
For the fetal liver E16.5 and E18.5 data sets, control and mutant
replicate groups were compared and genes were defined to be
differentially expressed if they were up or down regulated with a
fold change above 2 and a p-value below 0.05 (paired Welch t-
test).
For the adult liver data sets, genes were defined to be
differentially expressed if they were up or down-regulated with a
fold change above 1.5, a difference of means (absolute change)
above 75 (unlogged expression values) and Benjamini Hochberg
corrected p-values below 0.05 (Students t-test using log2
expression values) for samples undergoing PH or 0.001 for the
comparison between control and mutant prior to PH. All
microarray data are in compliance with MIAME and were
deposited in ArrayExpress (E-MEXP-2248 and E-MEXP-2249).
Hierarchical cluster heatmaps were generated from relevant subset
of genes in R (v.2.10.0) using complete linkage and Pearson
correlation distance measure.
Gene sets enrichment analyses were performed using the GSEA
software v2.04 and gene sets from the MSigDB available at www.
broad.mit.edu/gsea (permutation type gene sets, 1000 permuta-
tions). Enrichments plots from the GSEA program are shown
along with normalized enrichment scores (NES), P-values and false
detection rate q value for the corresponding gene sets [28]. q
values ,0.05 are considered significant.
Supporting Information
Figure S1 Loss of UPF2 during fetal liver development does not
affect proliferation rates, number of mitotic cells or apoptosis. (A)
Histological analysis of control (Upf2fl/f) and UPF2 null (Upf2fl/
fl; Alfp-Cre) E16.5 fetal livers stained with HE. (B) E18.5 UPF2
null fetal livers incorporate BrdU to similar extent as control livers.
(C) E16.5 UPF2 null fetal livers have similar number of mitotic
cells as assayed by phosphorylation of S10 of Histone H3. (D)
TUNEL staining of E16.5 UPF2 null and control fetal livers.
Found at: doi:10.1371/journal.pone.0011650.s001 (5.38 MB TIF)
Figure S2 Loss of UPF2 in adult liver does not induce apoptosis.
TUNEL staining of adult control and UPF2 null livers harvested
21 days post deletion.
Found at: doi:10.1371/journal.pone.0011650.s002 (1.77 MB TIF)
Figure S3 Loss of UPF2 functionally compromises the classical
complement pathway. FACS analysis of C3b deposition on K562
opsonised with antibodies against K562 using sera from control
(Upf2fl/fl) and UPF2 null (Upf2fl/fl;Mx1Cre) mice. Serum was
harvested 2 weeks post deletion of UPF2.
Found at: doi:10.1371/journal.pone.0011650.s003 (0.20 MB TIF)
Figure S4 Loss of UPF2 in adult liver leads to altered splicing
patterns. RT-PCR analysis of RNA isolated from adult control
(Upf2fl/fl) and UPF2 null (Upf2fl/fl; Mx1Cre) livers shows that
PTC-containing alternative spliced isoforms were stabilized for 9/
9 tested genes. Up-regulated splice isoforms are indicated by an
asterisk.
Found at: doi:10.1371/journal.pone.0011650.s004 (0.49 MB TIF)
Figure S5 UPF2 is essential for liver regeneration. Immunoflu-
orescence analysis of Ki67 expression before (0 h) or after (36 h)
PH of control and UPF2null BM transplanted mice.
Found at: doi:10.1371/journal.pone.0011650.s005 (2.18 MB TIF)
Table S1 Deregulated probesets in Upf2fl/fl; AlfpCre E16.5 and
E18.5 fetal livers. Probesets displaying expression fold changes
.2.0 or ,22.0 (paired Welsch test P,0.05) are depicted.
Found at: doi:10.1371/journal.pone.0011650.s006 (6.18 MB
XLS)
Table S2 SnoRNAs host genes and resident SnoRNAs.
SnoRNA host genes showing up-regulation in the indicated tissues
upon UPF2 truncation are depicted.
Found at: doi:10.1371/journal.pone.0011650.s007 (0.08 MB
DOC)
Table S3 Average affymetrix gene expression fold changes for
selected genes. In case of multiple probesets the set with the
highest expression levels are shown.
Found at: doi:10.1371/journal.pone.0011650.s008 (0.04 MB
DOC)
Table S4 GSEA of normalized gene expression datasets derived
from control and UPF2 null fetal livers at E16.5 and E18.5. The
top 100 up- and down-regulated gene sets are depicted for both
timepoints. See Supplemental Table S1 for lists of up- and down-
regulated probesets.
Found at: doi:10.1371/journal.pone.0011650.s009 (9.66 MB
XLS)
Table S5 Deregulated probesets in adult UPF2 null livers.
Probesets displaying expression fold changes .1.5 or ,21.5
(P,0.001) are depicted.
Found at: doi:10.1371/journal.pone.0011650.s010 (27.02 MB
XLS)
Table S6 GSEA of normalized gene expression datasets derived
from control and UPF2 null adult livers. The top 100 up- and
down-regulated gene sets are depicted. See Table S5 for lists of up-
and down-regulated probesets.
Found at: doi:10.1371/journal.pone.0011650.s011 (0.06 MB
XLS)
Table S7 Deregulated probesets in adult control and/or UPF2
null livers following PH. Probesets displaying expression fold
changes .1.5 or ,21.5 (P,0.05) are depicted.
Found at: doi:10.1371/journal.pone.0011650.s012 (2.71 MB
XLS)
Table S8 GSEA of normalized gene expression datasets derived
from control and UPF2 null adult livers following PH. The top
100 up- and down-regulated gene sets are depicted for phenotypes.
See Table S7 for lists of up- and down-regulated probesets.
Found at: doi:10.1371/journal.pone.0011650.s013 (0.10 MB
XLS)
Table S9 Primers used in this study.
Found at: doi:10.1371/journal.pone.0011650.s014 (0.07 MB
DOC)
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